Maxillofacial Plastic and Reconstructive Surgery

Korean Association of Maxillofacial Plastic and Reconstructive Surgeons (대한악안면성형재건외과학회)
권호 표지

EVALUATION OF ANGIOGENIC PHENOTYPES IN CULTURED HUMAN PERIOSTEAL-DERIVED CELLS UNDER HIGH-DOSE DEXAMETHASONE

고용량의 Dexamethasone 존재하에서 골막기원세포에서 발현되는 혈관신생인자의 평가

  • Park, Bong-Wook (Department of Oral and Maxillofacial Surgery, Gyeongsang National University School of Medicine and Institute of Health Sciences) ;
  • Choi, Mun-Jeong (Department of Oral and Maxillofacial Surgery, Gyeongsang National University School of Medicine and Institute of Health Sciences) ;
  • Ryu, Young-Mo (Department of Oral and Maxillofacial Surgery, Gyeongsang National University School of Medicine and Institute of Health Sciences) ;
  • Lee, Sung-Gyoon (Department of Oral and Maxillofacial Surgery, Gyeongsang National University School of Medicine and Institute of Health Sciences) ;
  • Hah, Young-Sool (Clinical Research Institute, Gyeongsang National University Hospital) ;
  • Kim, Deok-Ryong (Department of Biochemistry, Gyeongsang National University School of Medicine and Institute of Health Sciences) ;
  • Cho, Yeong-Cheol (Department of Oral and Maxillofacial Surgery, College of Medicine, Ulsan University) ;
  • Kim, Jong-Ryoul (Department of Oral and Maxillofacial Surgery, School of Dentistry, Pusan National University) ;
  • Byun, June-Ho (Department of Oral and Maxillofacial Surgery, Gyeongsang National University School of Medicine and Institute of Health Sciences)
  • 박봉욱 (경상대학교 의과대학/의학전문대학원 구강악안면외과학교실, 경상대학교 건강과학연구원) ;
  • 최문정 (경상대학교 의과대학/의학전문대학원 구강악안면외과학교실, 경상대학교 건강과학연구원) ;
  • 류영모 (경상대학교 의과대학/의학전문대학원 구강악안면외과학교실, 경상대학교 건강과학연구원) ;
  • 이성균 (경상대학교 의과대학/의학전문대학원 구강악안면외과학교실, 경상대학교 건강과학연구원) ;
  • 하영술 (경상대학교병원 임상의학연구소) ;
  • 김덕룡 (경상대학교 의과대학/의학전문대학원 생화학교실, 경상대학교 건강과학연구원) ;
  • 조영철 (울산대학교 의과대학 구강악안면외과학교실) ;
  • 김종렬 (부산대학교 치의학전문대학원 구강악안면외과학교실) ;
  • 변준호 (경상대학교 의과대학/의학전문대학원 구강악안면외과학교실, 경상대학교 건강과학연구원)
  • Published : 2008.05.30
Download PDF
⟨ Previous Next ⟩

Abstract

Angiogenesis plays an important role in bone development and postnatal bone fracture repair. Vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptors (VEGFRs) have been thought to be primarily involved in promoting angiogenesis. It is well known that VEGF and its receptors have been reported to play an important role in the regulation of the interaction between angiogenesis and osteogenesis during bone repair processes. Dexamethasone, a potent synthetic glucocorticoid, promotes phenotype markers of osteoblast differentiation, such as ALP and osteocalcin. It stimulates in vitro osteogenesis of human bone marrow osteogenic stromal cells. Dexamethasone has been reported to suppress VEGF gene expression in some cells. However, our previous study demonstrated VEGF quantification increased in a time-dependent manner in periosteal-derived osteogenesis under dexamethasone. So, the purpose of this study was to examine the angiogenic phenotypes in cultured human periosteal-derived cells under high-dose dexamethasone. Periosteal-derived cells were cultured using a technique previously described. After passage 3, the periosteal-derived cells were further cultured for 28 days in an osteogenic inductive culture medium containing ascorbic acid, ${\beta}$-glycerophosphate and high-dose dexamethasone, We evaluated the expression of VEGF isoforms, VEGFR-1, VEGFR-2, and neuropilin-1, ALL VEGF isoforms ($VEGF_{121},\;VEGF_{165},\;VEGF_{189}$, and $VEGF_{206}$) expression was observed by RT-PCR analysis. VEGFR-1, VEGFR-2 and neuropilin-1 expression increased up to day 14, particularly during the early stage of mineralization. Our results suggest the involvement of direct VEGFs/VEGFRs system on periosteal-derived cells during early mineralization phase under high-dose of dexamethasone. These also suggest that VEGF might act as an autocrine growth molecule during osteoblastic differentiation of cultured human periosteal-derived cells.

Keywords

References

  1. Park BW, Byun JH, Lee SG, et al : Evaluation of osteogenic activity and mineralization of cultured human periosteal-derived cells. J Kor Maxillofac Plast Reconstr Surg 28 : 511, 2006
  2. Park BW, Byun JH, Ryu YM, et al : Correlation between vascular endothelial growth factor signaling and mineralization during osteoblastic differentiation of cultured human periosteal-derived cells. J Kor Maxillofac Plast Reconstr Surg 29 : 197, 2007
  3. Feng D, Nagy JA, Hipp J, et al : Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin. J Exp Med 183 : 1981, 1996 https://doi.org/10.1084/jem.183.5.1981
  4. Neufeld G, Cohen T, Gengrinovitch S, et al : Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13 : 9, 1999 https://doi.org/10.1096/fasebj.13.1.9
  5. Dvorak HF : Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 20 : 4368, 2002 https://doi.org/10.1200/JCO.2002.10.088
  6. Gerber HP, Vu TH, Ryan AM, et al : VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5 : 623, 1999 https://doi.org/10.1038/9467
  7. Haper J, Gerstenfeld LC, Klagsbrun M : Neuropilin-1 expression in osteogenic cells: down-regulation during differentiation of osteoblasts into osteocytes. J Cell Biochem 81 : 82, 2001 https://doi.org/10.1002/1097-4644(20010401)81:1<82::AID-JCB1025>3.0.CO;2-P
  8. Tao O, Spring SC, Terman BI : Characterization of a new alternatively spliced neuropilin-1 isoform. Angiogenesis 6 : 39, 2003 https://doi.org/10.1023/A:1025884628155
  9. Mayer H, Bertram H, Lindenmaier W, et al : Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation. J Cell Biochem 95 : 827, 2005 https://doi.org/10.1002/jcb.20462
  10. Strizzi L, Catalano A, Vianale G, et al : Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma. J Pathol 193 : 468, 2001 https://doi.org/10.1002/path.824
  11. Tian X, Song S, Wu J, et al : Vascular endothelial growth factor: acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803. Biochem Biophys Res Commun 286 : 505, 2001 https://doi.org/10.1006/bbrc.2001.5409
  12. Masood R, Cai J, Zheng T, et al : Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. Blood 98 : 1904, 2001 https://doi.org/10.1182/blood.V98.6.1904
  13. Cheng SL, Yang JW, Rifas L, et al : Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology 134 : 277, 1994 https://doi.org/10.1210/en.134.1.277
  14. Yano A, Fujii Y, Iwai A, et al : Glucocorticoids suppress tumor angiogenesis and in vivo growth of prostate cancer cells. Clin Cancer Res 12 : 3003, 2006 https://doi.org/10.1158/1078-0432.CCR-05-2085
  15. Badrrudoja MA, Krouwer HG, Rand SD, et al : Antiangiogenic effects of dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood volume maps. Neuro Oncol 5 : 235, 2003 https://doi.org/10.1215/S1152851703000073
  16. Furumatsu T, Shen ZN, Kawai A, et al : Vascular endothelial growth factor principally acts as the main angiogenic factor in the early stage of human osteoblastogenesis. J Biochem 133 : 633, 2003 https://doi.org/10.1093/jb/mvg081
  17. Wang DS, Yamazaki K, Nohtomi K, et al : Increase of vascular endothelial growth factor mRNA expression by 1,25-dihydroxyvitamin D3 in human osteoblast-like cells. J Bone Miner Res 11 : 472, 1996
  18. Wang DS, Miura M, Demura H, et al : Anabolic effects of 1,25-dihydroxyvitamin D3 on osteoblasts are enhanced by vascular endothelial growth factor produced by osteoblasts and by growth factors produced by endothelial cells. Endocrinology 138 : 2953, 1997 https://doi.org/10.1210/en.138.7.2953
  19. Villars F, Bordenave L, Bareille R, et al : Effect of human endothelial cells on human bone marrow stromal cell phenotype: role of VEGF?. J Cell Biochem 79 : 672, 2000 https://doi.org/10.1002/1097-4644(20001215)79:4<672::AID-JCB150>3.0.CO;2-2